Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4C | Q9H3R0 | 10/20 | 0.53 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.53 |
| ▸ | KDM6B | O15054 | 4/20 | 0.53 |
| ▸ | KDM4D | Q6B0I6 | 3/20 | 0.53 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.53 |
| ▸ | KDM4A | O75164 | 2/20 | 0.53 |
| ▸ | MEN1 | O00255 | 1/20 | 0.53 |
| ▸ | MAPT | P10636 | 1/20 | 0.53 |
| ▸ | THRB | P10828 | 1/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.53 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.53 |
| ▸ | NAPRT | Q6XQN6 | 2/20 | 0.44 |
| ▸ | ASPH | Q12797 | 2/20 | 0.42 |
| ▸ | KDM8 | Q8N371 | 2/20 | 0.42 |
| ▸ | SIRT3 | Q9NTG7 | 1/20 | 0.42 |
| ▸ | APP | P05067 | 1/20 | 0.42 |
| ▸ | GAA | P10253 | 1/20 | 0.42 |
| ▸ | HCAR3 | P49019 | 1/20 | 0.42 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30316868 | 1.00 | KDM4C (0.53) | KDM4CKDM4EKDM6BKDM4DTDP1 | |
| SCHEMBL29578794 | 0.83 | KDM4C (0.59) | KDM4CKDM4EKDM6BKDM4DTDP1 | |
| SCHEMBL82604 | 0.83 | KDM4C (0.59) | KDM4CKDM4EKDM6BKDM4DTDP1 | |
| SCHEMBL16414200 | 0.81 | TDP1 (0.46) | KDM4CKDM4EKDM6BKDM4DTDP1 | |
| SCHEMBL30849093 | 0.81 | TDP1 (0.46) | KDM4CKDM4EKDM6BKDM4DTDP1 | |
| Hydrochloric Acid SCHEMBL1027857 | 0.81 | KDM4C (0.57) | KDM4CKDM4EKDM6BKDM4DTDP1 | |
| SCHEMBL2579028 | 0.81 | ALDH1A1 (0.52) | KDM4CKDM4EKDM6BKDM4DTDP1 | |
| SCHEMBL1135627 | 0.81 | SIRT3 (0.60) | KDM4CKDM4EKDM6BKDM4DTDP1 | |
| SCHEMBL8688700 | 0.80 | KEAP1 (0.43) | KDM4CKDM4EKDM6BKDM4DTDP1 | |
| SCHEMBL29416303 | 0.79 | KDM4C (0.65) | KDM4CKDM4EKDM6BKDM4DTDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 48 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116936810-B | Positive pole piece of sodium ion battery and sodium ion battery | 天鹏锂能技术(淮安)有限公司 | 2023-12-12 | — | — | CN | claimed |
| CN-116936810-A | Positive pole piece of sodium ion battery and sodium ion battery | 天鹏锂能技术(淮安)有限公司 | 2023-10-24 | — | — | CN | claimed |
| US-12559462-B2 | Pyrimidine derivatives as modulators of the 5-HT2A serotonin receptor useful for the treatment of disorders related thereto | ARENA PHARMACEUTICALS, INC. (US) | 2026-02-24 | — | — | US | disclosed |
| US-12545684-B2 | CDK2 inhibitors | BLUEPRINT MEDICINES CORPORATION (US) | 2026-02-10 | — | — | US | disclosed |
| US-20250270172-A1 | Pyrimidine Derivatives As Modulators of the 5-HT2A Serotonin Receptor Useful For The Treatment of Disorders Related Thereto | ARENA PHARMACEUTICALS, INC. (US) | 2025-08-28 | — | — | US | disclosed |
| US-20250236608-A1 | EGFR INHIBITORS | BLUEPRINT MEDICINES CORPORATION | 2025-07-24 | — | — | US | disclosed |
| EP-4236937-B1 | PYRIMIDINE DERIVATIVES AS MODULATORS OF THE 5-HT2A SEROTONIN RECEPTOR USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO | ARENA PHARM INC (US) | 2025-07-23 | — | — | EP | disclosed |
| CN-120136779-A | Preparation method of fluoro-azabenzene and derivatives thereof | 南开大学 | 2025-06-13 | — | — | CN | disclosed |
| US-20250073249-A1 | STEROID COMPOUND, AND PREPARATION METHOD THEREFOR AND USE THEREOF | SHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF SCIENCES (CN) | 2025-03-06 | — | — | US | disclosed |
| CN-119325471-A | EGFR inhibitors | 缆图药品公司 | 2025-01-17 | — | — | CN | disclosed |
| US-20240383902-A1 | CDK2 INHIBITORS | BLUEPRINT MEDICINES CORPORATION | 2024-11-21 | — | — | US | disclosed |
| CN-101605794-B | Azabenzofuranyl compounds and methods of use | GENENTECH INC US | 2013-06-12 | — | — | CN | disclosed |
| CN-102947305-A | Compounds and methods for kinase modulation and indications therefor | PLEXXIKON INC | 2013-02-27 | — | — | CN | disclosed |
| CN-102369188-A | Substituted nicotinamides as KCNQ2/3 modulators | GRUENENTHAL GMBH | 2012-03-07 | — | — | CN | disclosed |
| US-20120004208-A1 | BENZOYL-PIPERIDINE DERIVATIVES AS DUAL MODULATORS OF THE 5-HT2A AND D3 RECEPTORS | GOBBI LUCA (CH) | 2012-01-05 | — | — | US | disclosed |
| US-8039490-B2 | Benzoyl-piperidine derivatives as dual modulators of the 5-HT2A and D3 receptors | HOFFMANN-LA ROCHE INC. (US) | 2011-10-18 | — | — | US | disclosed |
| US-20090023733-A1 | Piperidine Derivatives, Their Process for Preparation, Their Use as Therapeutic Agents and Pharmaceutical Compositions Containing Them | ASTRAZENECA AB (SE) | 2009-01-22 | — | — | US | disclosed |
| CN-101223169-A | Pyrrolo [2, 3-b ] pyridine derivative protein kinase inhibitors | PLEXXIKON INC (US) | 2008-07-16 | — | — | CN | disclosed |
| US-5641727-A | Herbicidal 1-pyridyltetrazolinones | NIHON BAYER AGROCHEM K.K. (JP) | 1997-06-24 | — | — | US | disclosed |
| EP-0692482-A2 | 1-pyridyltetrazolinone derivatives | NIHON BAYER AGROCHEM K.K. (JP) | 1996-01-17 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250270172-A1 | Pyrimidine Derivatives As Modulators of the 5-HT2A Serotonin Receptor Useful For The Treatment of Disorders Related Thereto | HTR2A, HTR5A, HTR1A | KDM4C 4140/4885KDM4E 3934/4885KDM6B 1486/4885 |
| US-20120004208-A1 | BENZOYL-PIPERIDINE DERIVATIVES AS DUAL MODULATORS OF THE 5-HT2A AND D3 RECEPTORS | HTR2A, HTR3A, HTR2C | KDM4C 1762/4885KDM4E 1738/4885KDM6B 1644/4885 |
| US-20090023733-A1 | Piperidine Derivatives, Their Process for Preparation, Their Use as Therapeutic Agents and Pharmaceutical Compositions Containing Them | CCR3, CCR1, CCR5 | KDM4C 2144/4885KDM4E 2869/4885KDM6B 3871/4885 |
| US-12559462-B2 | Pyrimidine derivatives as modulators of the 5-HT2A serotonin receptor useful for the treatment of disorders related thereto | HTR2C, HTR1A, HTR2A | KDM4C 3084/4885KDM4E 4301/4885KDM6B 3010/4885 |
| US-20250236608-A1 | EGFR INHIBITORS | EGFR, ERBB2, ERBB3 | KDM4C 4433/4885KDM4E 3399/4885KDM6B 3280/4885 |
| US-20240383902-A1 | CDK2 INHIBITORS | CDK2, CDK20, CDK2AP1 | KDM4C 2990/4885KDM4E 2160/4885KDM6B 2112/4885 |
| US-20250073249-A1 | STEROID COMPOUND, AND PREPARATION METHOD THEREFOR AND USE THEREOF | NR5A1, CYP17A1, AR | KDM4C 4409/4885KDM4E 3740/4885KDM6B 4061/4885 |
| US-12545684-B2 | CDK2 inhibitors | CDK2, CDK4, CDK1 | KDM4C 1618/4885KDM4E 1727/4885KDM6B 3121/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.